Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical Misses on EPS, Stock Down 3.83%

Collegium Pharmaceutical reported an EPS of $0.22, significantly missing expectations, which contributed to a 3.83% decline in stock price. The lack of revenue information and guidance further adds uncertainty for investors. The market reaction suggests that investors were disappointed with the earnings performance.